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In laboratory lymphoblastoid cell lines and in natural human infections, Epstein-Barr virus (EBV) strains
have been identified by DNA restriction fragment length polymorphisms of the BamHI H fragment. Multiple,
heterogeneous BamHI H fragments have been detected in oral hairy leukoplakia (HLP), raising the question
of EBV coinfection with multiple strains. To investigate whether the heterogeneous BamHI H fragments
represent different EBV strains or recombinant variants of the same strain, EBV DNA from HLP lesions was
analyzed to characterize the viral strains and determine the source of possible recombinant variants. Clones
of heterogeneous BamHI H fragments from a single HLP lesion were determined to have strain identity on the
basis of sequence identity of the EBNA-2 genes. Intrastrain homologous recombination within the IR2 internal
repeat region and nonhomologous recombination of other sequences accounted for the heterogeneity of the
BamHI H fragments. PCR amplification from additional HLP specimens detected similar recombinant
variants. A possible example of site-specific recombination joining the BamHI Y portion of the EBNA-2 gene
to sequences within the BamHI S fragment was also detected in multiple HLP specimens. These data indicate
that intrastrain recombination during productive replication confounds the use of restriction fragment length
polymorphism analysis of the BamHI Y and H fragments to identify EBV strains in HLP. In patients with
permissive epithelial EBV infections, EBV strains could be more accurately distinguished by sequence identity
or divergence within known regions of genetic strain variation.
Oral hairy leukoplakia (HLP), a lesion occurring on the
lateral borders of the tongue in many patients infected with the
human immunodeficiency virus, is caused by the productive
replication of the Epstein-Barr virus (EBV) within mucosal
epithelial cells (23). Some HLP lesions are coinfected with
both EBV type 1 (EBV-1) and EBV-2, on the basis of typing of
the Epstein-Barr nuclear antigen 2 (EBNA-2) gene, and some
HLP lesions may be coinfected with multiple strains of the
same EBV type (55). During productive replication, the EBV
in HLP apparently recombines within the BamHI WYH
region, including the EBNA-2 gene, to generate viral variants
that are capable of replicating efficiently and persisting within
the lesion over time (55).
The EBV strains in lymphoblastoid cell lines (LCLs) can be
differentiated by BamHI H fragment size (6, 24), which differs
among strains in the number of 125-bp repeat units within the
IR2 internal repeat region. Based on these observations in
LCLs, restriction fragment length polymorphism analysis of
the BamHI H fragment has been used as a marker of EBV
strain identity and coinfection in studies of natural infections in
patients. In HLP, multiple fragments hybridize to probes
containing sequences from the BamHI H portion of the
EBNA-2 gene in the size range of 4.5 to 12 kb (55). These
heterogeneous BamHI H fragments could represent coinfec-
tion of HLP with different, genetically stable EBV strains, or
they could represent recombinant viral variants that differ in
the number of repeat units within IR2 (55). However, it was
difficult to attribute the large size of some of the BamHI H
fragments in HLP (8 to 12 kb) only to IR2 variation, suggesting
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that additional rearrangements may have occurred elsewhere
in the fragment.
The present study was designed to investigate the origin of
the BamHI H fragment heterogeneity in HLP by identifying
and characterizing the EBV strains and recombinant variants
present in clones from a single HLP specimen containing
multiple BamHI H fragments. Restriction mapping and se-
quence analysis of four clones demonstrated that multiple viral
variants were generated through recombination within the
BamHI Y and H regions of a single EBV strain. Although an
HLP lesion may be coinfected with multiple EBV types and
strains, numerous variants of EBV arise through intrastrain
recombination during productive viral replication, accounting
for much of the restriction fragment heterogeneity of the
BamHI Y and H fragments.
MATERUILS AND METHODS
Cloning ofHLP DNA. HLP biopsy specimens were obtained
from human immunodeficiency virus-seropositive, volunteer
patients, and the DNA was extracted as described elsewhere
(18, 43). DNA to be cloned was digested with HindIII, ligated
into cosmid vector Lorist B (34), and transfected into Esche-
richia coli NM554, which is a recA mutant and deficient for in
vitro recombination (Stratagene Cloning Systems, La Jolla,
Calif.). Subclones of the BamHI H and BsaMI fragments were
ligated into plasmid vector pGem3Z (Promega, Madison,
Wis.) and grown in E. coli DHSaF'IQ, which is also a recA
mutant and deficient for in vitro recombination (Gibco BRL,
Grand Island, N.Y.). The BamHI H fragment from LCL B95-8
was cloned into plasmid vector pGem2 (Promega) and grown
in E. coli DH5otF'IQ. Cosmid and plasmid DNA was extracted
from bacterial cell cultures by alkaline lysis and was purified on
Qiagen-tip columns (Qiagen Inc., Chatsworth, Calif.).
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FIG. 1. Schematic diagram of the BamHI YH region of the B95-8
EBV genome. The location of the EBNA-2 gene, the IR2 internal
repeat sequences, the BHLF1 gene, oriLyt, and the BHRF1 gene are
indicated. The hybridization domains of the probes used in the analysis
of this region are shown above the diagram. All probes are RNA
probes transcribed from viral DNA except IR2, which is a DNA
oligonucleotide probe whose specific hybridization domain is shown in
Fig. 3A. The 2A-H probe identifies the sequence from the BamHI H
region of the EBNA-2 gene, while the 2A-YH probe identifies both the
BamHI H and the BamHI Y portions of EBNA-2. Probe H identifies
sequences to the right of IR2, including oriLyt and the BHRF1 gene.
Probes and Southern blots. RNA probes used for Southern
blot hybridization were synthesized with [a-32P]UTP (Amer-
sham, Arlington Heights, Ill.) and either SP6, T3, or T7 RNA
polymerase (Promega). Probes 2A-H and 2A-YH have been
described previously (55). Probe H was derived from the
subcloned BamHI H fragment of B95-8 digested with NotI and
synthesized from the right end of the fragment. The hybridiza-
tion domains of these probes are illustrated in Fig. 1. Probes
2A-Y and S were derived from the insert of clone 4 (see
Results), subcloned in opposite orientations, digested with
SmaI to release either the BamHI Y or the BamHI S end of
the fragment, and synthesized from the desired end of the
remaining insert. Single-stranded DNA oligonucleotides were
synthesized and subsequently labeled with [y-32P]ATP (Amer-
sham) and T4 polynucleotide kinase (New England Biolabs,
Beverly, Mass.) for use as the probes designated IR2, F, Q, U,
P, and 0. The sequences of these probes are given in Table 1.
For hybridization to labeled probes, Southern blots of cloned
DNA were performed by agarose gel electrophoresis (SeaKem
agarose; FMC BioProducts, Rockland, Maine) and transfer of
DNA to supported nitrocellulose membrane (Micron Separa-
tions Inc., Westboro, Mass.).
DNA sequencing. DNA sequences were obtained from
cloned DNA by one of the following methods: (i) dideoxynu-
cleotide chain termination using [a-35S]ATP (Amersham) and
Sequenase enzyme (United States Biochemical, Cleveland,
Ohio) with denatured double-stranded DNA or with single-
stranded DNA generated by asymmetric PCR or (ii) PCR
dideoxynucleotide chain termination sequencing with Taq
polymerase (Promega) and with direct incorporation of [ct-35S]
ATP or with [-y-32P]ATP (Amersham)-end-labeled oligonucle-
otide primers. Sequencing reaction products were run on 6 to
8% polyacrylamide gels (Long Ranger; AT Biochem Inc.,
Malvern, Pa.). SP6 and T7 RNA polymerase promoter primers
(Promega) were used for sequencing reactions of subcloned
DNA. Single-stranded DNA oligonucleotides synthesized for
use as sequencing primers are listed in Table 1.
PCR amplification. PCR amplifications of HLP DNA were
performed using 2 U of Vent DNA polymerase (New England
Biolabs); a 1:10 dilution of 10x reaction buffer as supplied with
the Vent polymerase; 200 ,uM (each) dATP, dGTP, dCTP, and
dTTP; and a 0.5 pM concentration of each primer in 50- or
100-,ul reaction volumes. In some cases, 7-deaza-dGTP (Boehr-
inger Mannheim, Indianapolis, Ind.) was substituted for dGTP
in a ratio of 3:1 to increase amplification efficiency. Amplifi-
cation proceeded for a total of 40 cycles with denaturation at
98°C for 1 min, annealing at 55°C for 1 min, and extension at
72°C for 1.5 min. Single-stranded DNA oligonucleotides syn-
thesized for use as PCR primers are listed in Table 1. PCR
products were detected by hybridization with radiolabeled
probes after Southern blotting as described above.
RESULTS
Identification of BamHI-H heterogeneity. DNA from an
HLP lesion containing multiple BamHI H fragments of EBV-1
was digested with HindIII and cloned into the cosmid vector
Lorist B. Hybridization with the 2A-YH probe (Fig. 1) identi-
fied four clones of HindIII-B, a fragment that includes part or
all of the BamHI Y, H, F, Q, U, P, and 0 fragments. Clones 1,
2, and 3 contained BamHI H fragments of 6.4, 9.4, and 10.4 kb,
respectively (Fig. 2). Clone 4 was only 2.2 kb in size and had
TABLE 1. Oligonucleotides used for PCR, sequencing, and probes
Oligonucleotide Location Sequence (5'-3') Coordinates
IR2 probe IR2 CCGCCAGGTCCTGGGGCAGCCGGGGTTCCTGGCGCTCC 58578-50615
F probe BamHI-F CTCAAGCTTGCCTAATATCCTACTGGCTCA 55031-55008
Q probe BamHI-Q GTAATGTTGTCTGGTCGCTAGATGG 62359-62383
U probe BamHI-U AT'TTCCGGTAGGGCCATGAGCCGTT 66145-66169
P probe BamHI-P GAACACTYCATCTTCGAACATGTCT 69434-69458
0 probe BamHI-0 ACCGGCAGTATGCCTCGACGTCTGT 73502-73526
1 EBNA-2 CTCTCTAGACTATCTTGCGTTACATGGGGGACA 48515-48538
2 EBNA-2 TTGTGTCCAGGCATCCCTGCGCT 48827-48805
3 EBNA-2 AGGGATGCCTGGACACAA 48810-48827
4 EBNA-2 TGGGGTGCTTTGATG 49307-49293
5 EBNA-2 CATCAAAGCACCCCA 49293-49307
6 EBNA-2 AGGCATGCTAGGACTGGA 49652-49635
7 EBNA-2 TCCAGTCCTAGCATGCCT 49635-49652
8 EBNA-2 CTCCTGCAGCGAGGTCTITTACTGGGTCC 49952-49932
9 U2 TGCATAGGAGTGCGAACATGG 50236-50216
10 U2 GTCTGAGCATTCCATGGGCAGCA 50541-50563
11 U3 CCTGGGGGAGGGAACCGGGT 52356-52337
12 U3 CTCTCTAGAGGTGCATCTGGAACGGCTTACCT 53870-53892
13 BamHI-S CTCCTGCAGGCGATACTCTCAGTTAACGAGCA 86036-86014
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FIG. 2. Identification of the BamHI H fragment in four HLP
HindIII-B clones. Each clone was digested with HindIII or HindIII
plus BamHI in paired lanes. Hybridization with the 2A-YH probe
demonstrated a large (approximately 30-kb) HindIll B fragment which
contained a distinct BamHI H fragment in three of the clones: clone 1,
6.4 kb; clone 2, 9.4 kb; and clone 3, 10.4 kb. Clone 4 contained only a
2.2-kb HindH B fragment that lacked a BamHI restriction enzyme site.
lost the BamHI restriction site between BamHI-Y and -H (Fig.
2). Clones 1 to 3 were further analyzed by BamHI digestion
and hybridization with oligonucleotide probes to individually
identify the BamHI F, Q, U, P, and 0 fragments to the right of
the BamHI H fragment. These fragments were identical in size
for each clone, matching the predicted size based on the B95-8
genome (5) (data not shown). Thus, in these three clones, the
BamHI H fragment was the only variable fragment within the
approximately 30-kb HindIII B region.
EBV strain identification. To identify the EBV strains
represented, the sequences of the EBNA-2 genes were deter-
mined for clones 1 to 3. All three clones contained identical
EBNA-2 sequences, indicating that a single EBV strain was the
source of the variants; thus, the BamHI H fragment heteroge-
neity in this HLP developed through intrastrain recombina-
tion. The HLP EBNA-2 sequence was similar to that of W91
and distinct from that of B95-8, the two prototype EBV-1 LCL
strains (Table 2) (11, 13). The HLP EBNA-2 sequence con-
tained a 24-bp deletion of sequence from the polyproline
region, a 3-bp insertion, and a 3-bp deletion of sequence, each
preserving the open reading frame of the gene. Single-nucle-
otide substitutions usually resulted in conservative or similar
amino acid changes in the predicted protein sequence (Table
2). The sequence changes in the HLP EBNA-2 gene would not
disrupt the known EBNA-2 functional domains involved in
transcriptional transactivation and B-lymphocyte growth trans-
formation (11).
Recombination within the IR2 repetitive sequences. After
the BamHI H fragments of clones 1 to 3 were subcloned into
plasmid vectors, the IR2 regions of the three clones were
analyzed to determine the number of repeat units present in
each. The restriction enzyme NotI cuts only once within each
125-bp unit of IR2 and rarely within the rest of the EBV
genome. Partial digestion with NotI and hybridization with the
IR2 oligonucleotide probe generated a ladder array of bands
differing in size by 125 bp for each clone such that the total
number of repeat units in IR2 equaled one plus the number of
bands present in the ladder (Fig. 3). B95-8 demonstrated 10
bands, consistent with the presence of 11 repeat units (6, 14,
TABLE 2. HLP EBNA-2A coding sequence compared with those in B95-8 and W91 strains
B95-8 EBNA-2 Nucleotide Amino acid Conserved or similar EBNA-2 functional HLP W91
coordinate(s) codon change change amino acid domain strain strain
48687-48689 62 CTC- a Leu - Polyproline + Similar
48690-48692 63 CCA Pro - Polyproline + Similar
48693-48695 64 CCA - Pro - Polyproline + Similar
48696-48698 65 CCC - Pro - - Polyproline + Similar
48699-48701 66 CCC > Pro - Polyproline + Similar
49702-49704 67 CCA - Pro - - Polyproline + Similar
49705-49707 68 CCA Pro - Polyproline + Similar
49708-49710 69 CCA > Pro - - Polyproline + Similar
49722 73 C > T Pro > Pro + Polyproline - +
49731 76 C - T Pro > Pro + Polyproline + +
49740 79 C >T Pro >Pro + Polyproline + +
49749 82 C >T Pro >Pro + Polyproline + +
49759 86 C > T Pro - Ser + Polyproline + +
48990 163 A G Arg >Glu - Divergent + +
48991 163 G T Arg Val - Divergent + +
48998 165 C ->A Val Val + Divergent + +
49057 185 A -> G Gln Arg - Divergent + +
49091 196 G ->T Met > Ile + Divergent + +
49113 204 A T Thr Ser + Divergent + +
49136/49137 211/212 --CTC --Leu - Divergent + +
49170 223 C ->T Leu Leu + Divergent + +
49214 237 A -> C Glu > Asp + Divergent +
49449 316 C -- A His > Asn - Protein binding + +
49603 367 C >T Pro > Leu - Nonessential +
49613 370 T - A Pro > Pro + Nonessential + +
49754 417 G > A Thr > Thr + Nonessential + +
49913 470 A >T Ser Ser + Acidic + +
49917-49919 472 GAA Glu - - Acidic + -
49923 474 T-C Tyr Asn - Acidic - +
49930 476 A - G Glu -Gly - Nuclear localization + +
49956 485 T C Ser - Pro + Nuclear localization + +
a-, deleted.
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24, 25), and clone 1 demonstrated 15 bands, indicating the
presence of 16 repeat units in IR2.
However, both clone 2 and clone 3 demonstrated two
distinct ladders each, with 9 and 15 bands and 12 and 23 bands,
respectively. The double ladder sets in the BamHI H fragments
of these two clones indicated the presence in each clone of two
separate IR2 regions, separated by a unique sequence. In this
partial-digestion analysis, the lower ladder represented the IR2
region with the most repeats, whereas the upper ladder
represented the total number of 125-bp repeat units present
within both IR2 regions. Thus, clone 2 contained IR2 regions
of 10 and 6 repeat units, and clone 3 contained IR2 regions of
13 and 11 repeat units. These data indicated that some of the
BamHI H fragment size variation in HLP was due to homologous
recombination in the IR2 repeat regions. Duplication of the IR2
regions in clones 2 and 3 indicated that additional rearrangements
had occurred in the unique sequences of the BamHI H fragment.
Recombination and rearrangement of the BamHI H frag-
ment. To characterize the rearrangements in the unique
sequences, the BamHI H fragments from clones 1 to 3 were
mapped with three restriction enzymes that conveniently cut at
sequences between EBNA-2 and IR2 and within sequences of
the BHLF1 gene and the lytic origin of viral replication
(oriLyt) (Fig. 4). Replicates of each digest were hybridized to
probes 2A-H, IR2, and H (Fig. 1). Each of the three enzyme
digestions generated subfragmrents of the three clones that
were compared with those of the B95-8 BamHI H fragment
(Fig. 4), thereby allowing derivation of the organizational
structure of the three HLP BamHI H fragments. Clone 1 (Fig.
5) demonstrated the typical BamHI H fragment structure,
differing from B95-8 in the total number of 125-bp repeat
elements in IR2 and in the absence of the BsaMI site in the U3
region to the right of IR2. Clones 2 and 3 departed markedly
from the typical BamHI H fragment structure but differed
from each other only in the sizes of their IR2 regions (Fig. 6).
As predicted by the NotI digestions, they each contained
duplicate IR2 regions, separated by 3 kb of unique sequence
derived from the BamHI H fragment.
To further define the structure of clones 2 and 3, the two
large BsaMI fragments containing the duplicated sequences
were subcloned. Repeated NotI partial-digestion analysis of
the two BsaMI subclones of clone 2 confirmed the presence of
10 and 6 repeat units in the IR2 regions of clone 2 (data not
shown). Sequence analysis confirmed the structural organiza-
tion of clones 2 and 3, including the order of the IR2 regions
and the recombination site between the U3 sequence to the
right of oriLyt and the EBNA-2 sequence (Fig. 6). In both
clones, nonhomologous recombination occurred, linking bp
54208 in U3 to bp 49802 in the carboxy-terminal end of
EBNA-2. This event resulted in the complete duplication of
the BHLF1 gene and the sequences of oriLyt.
The BamHI H fragments of clones 1 to 3 each lost the
BsaMI site in BHLF1 to the right of IR2 but differed in the
number of repeat units within IR2 (Fig. 5 and 6). Therefore,
the unique DNA sequences from U2 and U3 immediately
surrounding IR2 were examined in the three clones. All three
clones contained identical sequences around the U2-IR2 junc-
tion, matching B95-8 and including the first 38-bp incomplete
repeat unit of IR2. Examination of the sequence around the
IR2-U3 junction in clone 1 demonstrated a 225-bp in-frame
deletion linking the 25th base pair of the last repeat of IR2
with bp 52240 of U3. This recombination took place at an 8-bp
sequence of homology between the two sites: CCGCCGGT.
Similarly, at all four IR2-U3 junctions within clones 2 and 3,
there was a 117-bp in-frame deletion linking the 105th base
pair of the last repeat of IR2 with bp 52212 of U3. The
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FIG. 3. NotI partial digestion analysis of the BamHI H fragment
subclones. (A) Partial digestion with NotI produced ladders of bands
differing in size by multiples of 125 bp. Flanked by unique sequences
U2 and U3, IR2 in the B95-8 strain contains a 38-bp incomplete copy
of the repeat unit before the series of complete units. Given the
location of the NotI restriction site and the hybridization domain of the
oligoprobe, the number of copies of the repeat unit is one more than
the maximum number of bands in the ladder. (B) B95-8, with 11 copies
of the repeat unit, demonstrated 10 bands in this assay. The ladder in
clone 1 contained 15 bands, indicating 16 copies. Clones 2 and 3
demonstrated ladders of 9 and 12 bands, respectively. (C) Clones 2 and
3 each contained a second ladder of bands, indicating two separate
copies of the IR2 repeat region. In clone 2, the second ladder of 2.9-
to 4.7-kb fragments contained 15 bands, indicating a total of 16 copies
in both IR2 regions in this clone. In clone 3, the second ladder of 2.9-
to 5.8-kb fragments contained 23 bands, indicating a total of 24 copies
in both IR2 regions in this clone.
recombinations in clones 2 and 3 took place at a 7-bp sequence
of homology between the two sites: CTGGGGC. These data
indicated that homologous recombination of the IR2 se-
quences may also include nearby unique sequences and sug-
gested that some degree of site specificity is involved.
To further evaluate variation among clones 1 to 3, the
sequences of the partially duplicated EBNA-2 genes from
clones 2 and 3 were examined. Codon 472 (GAA) that had
been deleted from the complete EBNA-2 sequences of clones
1 to 3 (Table 2) was present in the partially duplicated EBNA-2
sequences of clones 2 and 3. Thus, the deletion of codon 472
represented another intrastrain recombination event that oc-
curred independently of the U3-EBNA-2 recombination and
the deletions at the IR2-U3 junction. These structural and
sequence variations among clones 1 to 3 (Fig. 7) indicated that
a complex series of recombination events gave rise to several
different intrastrain viral variants, accounting for much of the
BamHI H-fragment heterogeneity in this HLP.
BamHI H-fragment recombination in permissive infection
in vivo. To determine if BamHI-H duplications occurred in
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other HLP samples, PCR primers that flanked the U3-
EBNA-2 junction site were chosen. Amplification of DNA
from clone 2, and from the original HLP specimen from which
clone 2 was obtained, generated the predicted product size of
442 bp (Fig. 8). HLP specimens from several additional
patients were examined by PCR amplification with these
primers. Notably, the PCR products detected in these HLP
specimens ranged in size from 442 to 1,600 bp (Fig. 8). The
442-bp PCR product did not hybridize to the probe 2A-H
because of the small amount of EBNA-2 sequence between the
PCR primer and the recombination junction with the U3
sequence. Many but not all PCR products larger than 442 bp
did hybridize to probe 2A-H, indicating a greater portion of
EBNA-2 sequence in these products. Similarly, many but not
all PCR products hybridized with probe H. These data sug-
gested variation among and within HLP specimens for the site
of recombination in both the EBNA-2 and U3 sequences.
Thus, the EBNA-2-U3 recombinations in HLP were quite
variable and both nonhomologous and non-site specific. In
three additional patients, some of the PCR product bands were
detected in sequential biopsy samples from the same patient
(data not shown), suggesting that some of the viral variants
replicated and persisted. These data are consistent with South-
ern blot hybridizations demonstrating large BamHI H frag-
ments (8 to 12 kb) persisting within serial HLP biopsy samples
from the same lesion (55).
Defective EBV and detection in permissive infection in vivo.
Clone 4 contained a 2.2-kb insert with the EBNA-2 sequence
that lacked the expected BamHI site between the BamHI Y
and H fragments (Fig. 2). Subcloning and sequencing clone 4
demonstrated recombination between the BamHI Y portion of
EBNA-2 and distant EBV sequences from the BamHI S
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FIG. 4. Restriction enzyme digestion of the three BamHI H frag-
ments of clones 1 to 3. Agarose gels stained with ethidium bromide are
shown for each digestion. (A) Based on the predicted restriction sites
for the BamHI H fragment of B95-8, digestion with BsaMI, NcoI, and
SmaI allowed fine mapping of the regions flanking IR2 and of oriLyt.
(B) BsaMI digestion demonstrated a 1,650-bp fragment that hybrid-
ized to the probe 2A-H in all three clones. B95-8 demonstrated
fragments that hybridized to probe IR2 (1,600 bp) and probe H (2,700
bp). Clone 1 contained a single 4,700-bp fragment that hybridized to
both the IR2 and H probes, indicating a fusion of the two fragments
containing IR2 and oriLyt. Clones 2 and 3 each also demonstrated two
fused fragments that hybridized to both the IR2 and H probes (clone
2, 3,600 and 4,100 bp; clone 3, 4,000 and 4,400 bp). (C) NcoI digestion
demonstrated a 620-bp band that hybridized to probe 2A-H in B95-8
and all three clones. The 950-bp band of B95-8 and an 800-bp band in
clones 1 to 3 also hybridized to probe 2A-H, indicating the presence of
an NcoI site within the U2 region of clones 1 to 3 that was not present
in B95-8. Each of the three clones and B95-8 contained a 2,300-bp
fragment that hybridized to probe H. Clones 2 and 3 each contained an
additional 2,200-bp fragment that also hybridized to probe H. Frag-
ments that hybridized to probe IR2 were detected in B95-8 (2,000 bp),
clone 1 (2,250 bp), clone 2 (1,150 and 1,650 bp), and clone 3 (1,650 and
2,050 bp). (D) SmaI digestion demonstrated fragments in B95-8 and
clone 1 of 260, 1,050, and 1,120 bp that hybridized with probe H. These
same three fragments were detected in clones 2 and 3 at double the
intensity of fluorescence, indicating duplication of these fragments in
these two clones. B95-8 and all three clones also contained a 1,700-bp
fragment that hybridized to probe 2A-H. Fragments that hybridized to
probe IR2 were detected in B95-8 (1,780 bp), clone 1 (2,150 bp), clone
2 (940 and 1,500 bp), and clone 3 (1,525 and 1,850 bp).
region. The EBNA-2 sequence in clone 4 matched identically
with that in clones 1 to 3. Thus, clone 4 represented another
variant of the same original strain, arising through recombina-
tion within the HLP lesion. The recombination took place
within the polyproline region of the EBNA-2 gene, with bp
48737 of EBNA-2 linked to bp 85777 of BamHI-S (Fig. 9).
Similar to the IR2-U3 recombinations, this recombination site
also shared an 8-bp sequence homology between BamHI-Y
and BamHI-S: CTCCACCA. As a result of this recombination,
the EBNA-2 open reading frame was truncated by a stop
codon 24 bp beyond the recombination site. The BSLF1 gene
was also truncated by a stop codon in BamHI-Y, preserving
less than half of its potential amino acid sequence (Fig. 9).
An RNA probe synthesized from the entire insert of clone 4
was hybridized by Southern blot back to the HLP DNA from
which it was cloned. Both the standard BamHI Y and BamHI
S fragments were easily detected by this probe, but a 2.2-kb
fragment was not detected (data not shown), indicating a low
copy number of the EBNA-2-BamHI-S recombinant molecule
within the HLP lesion.
To determine if this EBNA-2-BamHI-S recombination had
occurred in other HLP lesions, PCR primers that flanked the
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FIG. 5. Organizational structure of the BamHI H fragment of
clone 1. For each restriction enzyme digestion (BsaMI, NcoI, and
SmaI), hybridization with probes 2A-H, IR2, and H identified the
fragments as shown. Clone 1 demonstrated the prototype BamHI-H
structure, differing from B95-8 only in the number of repeat elements
present in IR2 and the loss of the BsaMI site in BHLF1.
BH L.F1
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FIG. 7. Sequence analysis of clones 1 to 3. Clone 1 contained a
225-bp deletion within BHLF1 that spanned the IR-U3 junction.
Clones 2 and 3 contained identical 117-bp deletions at both of their
IR2-U3 junctions. Codon 472 (GAA), deleted from within the com-
plete EBNA-2 sequence of all three clones, was present in the small
piece of EBNA-2 sequence involved with the U3 recombination of
clones 2 and 3.
EBNA-2-BamHI-S junction site were chosen. Amplification of
DNA from clone 4, and from the original HLP lesion from
which clone 4 was obtained, generated the predicted product
size of 477 bp (Fig. 10). PCR amplification of additional HLP
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clone 3 contained 13 and 11 cc
biopsy specimens produced a 477-bp product in samples from
7 of 15 patients (Fig. 10 and data not shown). The products
hybridized with both probes 2A-Y and S. In three cases, the
EBNA-2-BamHI-S variants were detected in sequential HLP
biopsy specimens from the same patient (Fig. 10 and data not
shown). Unlike the U3-EBNA-2 recombinations, the EBNA-
2-BamHI-S recombination demonstrated no heterogeneity in
product size, suggesting that CTCCACCA may constitute a
site-specific sequence for EBV recombination generating de-
fective EBV in permissive infection.
DISCUSSION
B Hi Accurate identification of EBV types, strains, and recombi-
H IR 2 + ] nant variants is required for the study of the epidemiology and
=-~T natural history of EBV infection. EBV-1 and -2 are distin-
BsaMI guished by regions of sequence divergence within several
EBNA genes that differentially hybridize to type-specific
BamHI probes (1, 13, 30, 46, 49, 50, 55). In LCLs, EBV strains have
H IR 2 H been identified by restriction fragment length polymorphism
analysis of EBV fragments containing internal repetitive se-
Ncol NcoI quences. Each strain is characterized by unique and stable
differences in the number of repeat units present, even after
BamHI induction of lytic replication (6, 12, 14, 24, 25). Similarly, many
i H - IR 2 H H H _J of the EBNA proteins expressed in LCLs vary in size among
] I I I rr strains because of variable repeat regions within their coding
iiSmal Smal Smal SmaiSmal sequences, resulting in a unique EBNotype signature by West-
cture of the BamHI H fragments of ern blot (immunoblot) for each strain (17). Based on these
iction enzyme digestion (BsaMI, NcoI, observations in LCLs, epidemiological studies of EBV isolates
)robes 2A-H, IR2, and H identified the from natural infections have relied on restriction fragment
ted by the Notl digestion, clones 2 and length polymorphism and EBNotype analysis to determine
he IR2 region arising from a recombi- multiplicity of infection and to monitor strains through time
to the right of oriLyt and EBNA-2 througl sequetof lnfect ions inboth healthyopatimealso resulted in a complete duplication and through sequential inco n both healthy patients (19,
MI site was absent from both copies of 28, 35-37,49, 56) and immunocompromised patients (7, 2022,
ed only in the number of repeat units 27, 28, 49, 55).
[one 2 contained 10 and 6 copies, while However, homologous recombination within repetitive se-
)pies. quences frequently generates variation (3, 38), and homolo-
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FIG. 8. PCR amplification of the U3-EBNA-2 recombination junc-
tion from the HLP samples of 12 patients. The PCR products were
amplified with oligonucleotide primers 8 and 12 and are shown stained
with ethidium bromide (Et-Br) and after hybridization with probes H
and 2A-H. Clone 2 was a positive control and demonstrated the
predicted 442-bp product. Patient A, from whom clone 2 was obtained,
also demonstrated the 442-bp product from biopsy samples taken at
two different time points. Patients B to L demonstrated a heteroge-
neous variety of PCR product sizes.
gous recombination in EBV is closely linked with productive
replication (54). In the present study of HLP, homologous
recombination within the IR2 sequences contributed to the
size variation of the BamHI H fragment, indicating that
BamHI-H variation does not actually distinguish strains. Sim-
ilarly, repetitive sequences within the latent membrane protein
1 gene recombine during replication in HLP to generate
intrastrain variation (41). By analogy, other repetitive se-
quences within the BamHI K and Bi fragments and the EBNA
genes may also experience intrastrain homologous recombina-
tion (55). Thus, in HLP, intrastrain recombination would
obscure the identification of EBV strains based on variation in
these fragments or gene products. Even without HLP, immu-
nocompromised patients demonstrate continuous, high-level
EBV replication and shedding of virions in the oropharynx (2,
8, 52). Given this degree of viral replication, homologous
recombination could produce EBV intrastrain variation in
these patients as well. Thus, in permissive epithelial infections
of immunocompromised patients, EBV strains could be more
accurately distinguished by sequence identity or divergence
within known regions of genetic strain variation, such as the
EBNA-2 or latent membrane protein 1 gene (11, 41).
In the present study, variation of the 125-bp repeat units in
IR2 resulted from unequal pairing of homologous DNA
strands with subsequent crossover recombination. However,
the recombination events at the IR2-U3 junction involved
short (7- to 8-bp) sequence homologies, suggesting some
degree of site specificity for the recombination event. In vitro
recombination studies have shown for mammalian cells that
greater than 200 bp of homology are required for efficient
homologous recombination but that 14 to 25 bp are adequate,
if very inefficient (4, 33, 45). In herpes simplex virus type 1,
random double-stranded DNA breaks in the semirepetitive a
sequences and homologous recombination are responsible for
genome isomerization during viral replication and packaging
(16, 48). Consequently, several "illegitimate" recombination




FIG. 9. Sequence analysis of the 2.2-kb HindIII insert of clone 4.
Recombination between the BamHI Y portion of EBNA-2 and se-
quences of the BamHI S region linked bp 48737 to bp 85777 at an 8-bp
sequence homology between BamHI-Y and BamHI-S: CTCCACCA.
The EBNA-2 open reading frame was truncated by a stop codon 24 bp
beyond the recombination site, and the BSLF1 open reading frame was
truncated by a stop codon in BamHI-Y.
quences with other regions of the herpes simplex type genome
having short sequence homologies of 10 to 12 bp have been
previously described (29, 42). A similar illegitimate mechanism
may account for the two different IR2-U3 deletion patterns
demonstrated for clone 1 (225 bp) and clones 2 and 3 (117 bp).
The EBNA-2-BamHI-S recombination also involved an
8-bp sequence homology at the recombination site. However,
the independent occurrence of this specific recombination in
multiple HLP specimens suggests a site-specifically mediated
recombination mechanism. The CTCCACCA recombination
site shares features with many of the published recombination
recognition sequences of prokaryotic and eukaryotic systems,
including an 8-bp length and a high G+C content (15).
The P3HR-1 cell line, originally selected for high virus
production, is an example in which nonhomologous recombi-
nation between normally distant regions of the EBV genome
generated defective molecules in lymphocytes (9, 39). These
molecules, which include juxtapositions of BamHI-W with
BamHI-Z (WZhet), have been shown to be responsible for the
unusual biologic properties of the P3HR-1 strain (40). The
exact sequences involved at most of the P3HR-1 recombina-
tion sites have not been determined. However, the data
presented here indicate that nonhomologous, non-site-specific
recombination frequently occurs between nonrepetitive DNA
sequences during EBV replication in vivo. Similar to the
U3-EBNA-2 recombinations, WZhet DNA and deletions of
the EBNA-2 gene detected in HLP specimens also demon-
strate variability in their sites of nonhomologous recombina-
tion (26, 43, 51).
In addition to the presence of defective genomes, the
P3HR-1 strain is also deleted for the EBNA-2 gene, and viral
0
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FIG. 10. PCR amplification of the EBNA-2-BamHI-S recombina-
tion junction from the HLP samples of 12 patients. The PCR products
were amplified with oligonucleotide primers 1 and 13 and are shown
after hybridization with probe 2A-Y. Clone 4 was a positive control
and demonstrated the predicted 477-bp product. The 477-bp product
was detected at two different time points in patient A, from whom
clone 4 was obtained, and in patients B, C, K, and L.
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variants defective for EBNA-2 are commonly detected in HLP
(51, 55). EBNA-2 is an important regulatory gene early in
B-lymphocyte infection and is essential for B-lymphocyte
transformation (11, 44). Thus, the viral variants with the
EBNA-2-BamHI-S recombination would be incapable of es-
tablishing latency and immortalizing B lymphocytes (10, 11, 31,
32). The role of EBNA-2 in epithelial infection is less clear.
Latently infected nasopharyngeal carcinoma cells do not ex-
press EBNA-2 (57), and EBNA-2 is not required for produc-
tive replication in the oropharynx (51). It is unclear whether
the EBNA-2 gene product is expressed in HLP (47, 53).
However, the prevalence and persistence of the EBNA-2-
BamHI-S recombinant and other EBNA-2-defective variants
in HLP (51, 55) suggest a selective advantage for these viral
variants in a permissive environment. Thus, the role of the
defective variants in the pathogenesis of HLP merits further
investigation.
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